Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2019 | Story Valentino Ndaba | Photo Ernst & Young
UFS Accounting Students win EY Project Alpha
At the Ernst & Young Project Alpha 2019 Awards, some of the members of the winning team, from left: Kyle du Bruyn, Luke Rhode, Janri du Toit, Nicolaas van Zyl, Mojalefa Mosala (Business Ethics Lecturer), Bianca Malan, Lorandi Koegelenberg and Frans Benecke.

A few years ago the news was saturated with Volkswagen’s (VW) fuel emission scandal. “Dieselgate”. Investigations in the US found the German automaker guilty of programming computers in their diesel cars to alter its engine operations to seemingly meet legal emission standards.

A question of ethics

A notice of violation of the Clean Air Act issued by the US Environmental Protection Agency had dire consequences for the automobile company, but positive implications for the economy and the environment. As part of a lawsuit settlement, vehicles were recalled, fines were paid, and approximately 21 million affected vehicles with VW diesel engines were refitted by September 2015.

Project Alpha tackles ethical issues

A group of eight students from the University of the Free State (UFS) presented their case study of “Dieselgate” to a panel of judges in this year’s Ernst & Young Project Alpha competition. They emerged as the ultimate winners.

The “Hoaxwagen” group’s 10-minute video demonstrated “a critical assessment of a multidimensional matter”   captivating the judges. “I was impressed, because their presentation addressed other skills such as the ability to present, communicate, come out of their comfort zone and be innovative, while at the same time addressing an ethical issue,” said Mojalefa Mosala, a judge and Business Ethics lecturer at the UFS.

Centred on critical thinking

The UFS is the first university outside of Johannesburg that participated in the Project Alpha contest. Ernst & Young and the UFS have forged a strong relationship over the past few years, giving students a glimpse into the corporate world of accounting. 

“Project Alpha encourages critical thinking and not taking things at face value, by looking a bit deeper, spending time to understand the pros and cons of any situation in order to make an informed decision,” said Frans Benecke, member. of the winning team that prevailed over 82 others. Benecke’s team walked away with R2000 shopping vouchers and a life-long learning experience.

Engaging in global conversations 

Participation in the competition gave students the opportunity to be exposed to contemporary global thinking, which is strongly advocated in the UFS’s Integrated Transformation Plan.


UFS Accounting students win 2019 Ernst & Young Project Alpha competition from University of the Free State on Vimeo.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept